Home On The Range : Researchers Discover Success In Montana

In the book Shoeless Joe, better known as the movie Field of Dreams, the main character converts an Iowa cornfield into a baseball field after a voice says, "If you build it, he will come." In Great Falls, Mont., supporters of the McLaughlin Research Institute (MRI) began construction of a 42,000 square-foot, state-of-the-art, genetics research facility on prairie farmland in 1991 with the hope that if they built it, scientists would come. The new building, constructed with federal and state f

Written byCarol Potera
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

The new building, constructed with federal and state funds, was completed in 1993. And the researchers have indeed come, inspired by quality-of-life issues that are making Montana's remoteness attractive. Montana's two state universities and a federal biomedical research laboratory also are experiencing the boon of scientists wanting to seek their fortunes in the state.

Just 20 to 30 years ago, scientists who came to Montana ran the risk of jeopardizing their careers. The state's seclusion limited professional contacts with colleagues, and equipment was inferior to those at urban research centers. But those who took the chance now find that advances in telecommunications and changing attitudes toward rural lifestyles have brought once-isolated Montana researchers into the mainstream. Whereas recruiting scientists from within was once a necessary standard practice, now hundreds of applicants vie for each new job opening. Often called the last best place to live, Montana is shaping up as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies